Please login to the form below

Breast Cancer Now

This page shows the latest Breast Cancer Now news and features for those working in and with pharma, biotech and healthcare.

Lynparza set for further expansion with EU approval in breast cancer

There were an estimated 2.1m new cases of breast cancer worldwide last year, and around 30% of women diagnosed with early breast cancer will go on to develop advanced disease. ... The OlympiAD trial supported the approval, and showed Lynparza produced an

Latest news

Tecentriq gains first IO approval in triple negative breast cancer

A coup for Roche in IO field dominated by Keytruda. Roche has stolen a march on market leader Keytruda by gaining the first immuno-oncology approval in triple negative breast cancer. ... Tecentriq (atezolizumab) can now be used in combination with
NICE gives Lilly’s Verzenios chance to compete with rivals

Around 46, 000 women are diagnosed with breast cancer each year in England and Wales, of whom around 8, 000 would be eligible for treatment with a CDK4/6 inhibitor. ... Baroness Delyth Morgan, chief executive at Breast Cancer Now (pictured) welcomed
Daily Brief: Tecentriq set for breast cancer filing, Ocrevus gets NICE thumbs down, NHS needs more cash

Our round-up from pharma, biotech and healthcaare. Tecentriq takes the lead in immunotherapy for breast cancer. ... Checkpoint inhibitor immunotherapy drugs have targeted other tumour types before turning to breast cancer, but now Roche's Tecentriq looks
Daily Brief: Amgen offers Repatha deals in Europe, will Persephone slash Herceptin use?

Baroness Delyth Morgan, Chief Executive at UK charity Breast Cancer Now (pictured) said: “This marks a really promising step towards being able to safely offer patients a much shorter course of ... Herceptin remains one of the most important
NICE backs two advanced breast cancer drugs after price cuts

Women in England and Wales with advanced breast cancer can now get access to two CDK 4/6 inhibitor drugs - Pfizer’s Ibrance and Novartis’ Kisqali - after pricing negotiations between the ... important breakthroughs for women with advanced breast

More from news
Approximately 2 fully matching, plus 31 partially matching documents found.

Latest Intelligence

30 Women Leaders in UK Healthcare (part 3)

28. Baroness Delyth Morgan, Breast Cancer Now Chief Executive. Delyth has been a central figure in breast cancer charities for more than 20 years, building the sector’s voice in health ... In 2015 she oversaw the merger of her organisation Breast
Engaging the digital healthcare professional

Two days after the student midwife’s tweet, UK organisation Breast Cancer Now shared its own response to the guidance, also tweeting to Pfizer and NICE and urging them to work ... Breast Cancer Now is followed by almost 40, 000, and its tweet, which it

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer

Misconception. Reality. Pancreatic cancer is rare [8]. Although the incidence of pancreatic cancer is lower than other common cancers like breast, bowel and lung, pancreatic cancer is the 5. ... Unless substantial improvements are made now, pancreatic

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Senior Medical Writer: Salary TBC

Director – Healthcare PR: Salary TBC

Editorial / Copy Lead – Healthcare Advertising – Central London...: Salary TBC

Editorial/ Medical Director – Med Ed & Comms – Home-based...: Salary TBC

Hybrid Role - Principal Medical Writer / Account Handler - Publi...: Salary TBC

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Home-based Principal Medical Writer – Medical Comms: Salary TBC

Senior / Principal Medical Writer - MedComms - Home Based / Vari...: Excellent Remuneration Packages

Senior Medical Writer: Competitive salary and benefits

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Senior Account Director/ Associate Director- Pharma and Life Sci...: Competitive salary and benefits

Project Manager - Medical Communications – South Wales: Excellent Remuneration Package

Account Director, Medical Education: Salary TBC

Account Director – London based Medical Communications Agency: Excellent Remuneration Package

Freelance Medical Writer - Healthcare Advertising - London: Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day

PR Associate Director – Consumer Health & Beauty: Salary TBC

Project Manager - Digital Healthcare - London: Excellent Remuneration Package

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Account Manager / Senior Account Manager - Healthcare Advertisin...: Excellent Remuneration

Editor – Medical Education Agency – Bucks: Salary TBC

Experienced / Senior Account Director - Publications - London: Up to £80, 000 plus great benefits

Senior Account Manager- Pharma and Life Scienes: Competitive salary and benefits

Subscribe to our email news alerts

PMHub

Add my company

wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality: How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA: Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad: Six behaviours separate the good brand teams from the bad...